NCT05054907

Brief Summary

This study is going to use wearable devices and smartphones to collect physical data from terminal patients and build a survival predicting model for terminal patients with machine learning. Investigators hypothesize that continuous physical data monitoring could offer a hint to better predictability in end-of-life care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2021

Completed
24 days until next milestone

First Posted

Study publicly available on registry

September 23, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

September 23, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
Last Updated

November 9, 2022

Status Verified

November 1, 2022

Enrollment Period

1.3 years

First QC Date

August 30, 2021

Last Update Submit

November 6, 2022

Conditions

Keywords

palliativecancersurvival predictionartificial intelligencewearable devices

Outcome Measures

Primary Outcomes (2)

  • Area Under the Receiver Operating Characteristic curve (AUC-ROC) of the machine-learning model to predict survival using wearable device parameters and clinical assessment

    Measured data from wearable device and regular assessment (including medical condition, laboratory data, symptom, functional assessment) will be integrated to build one machine-learning model to predict patients' death or survival within specific time range. The primary outcome is to evaluate the Area Under the Receiver Operating Characteristic curve (AUC - ROC) of the machine-learning model in predicting patients' survival.

    From date of enrollment until the date of death, or assessed up to 26 weeks. Wearable device parameters are collected continuously. Other clinical assessments are performed every week. Death or survival is recorded at the time the case closed.

  • Area Under the Receiver Operating Characteristic curve (AUC-ROC) of machine-learning model to predict unexpected medical needs using wearable device parameters and clinical assessment

    Measured data from wearable device and regular assessment (including medical condition, laboratory data, symptom, functional assessment) will be integrated to build one machine-learning model to predict patient's unexpected medical needs (which is defined as emergency department visit or unplanned admission to hospital). The primary outcome is to evaluate Area Under the Receiver Operating Characteristic curve (AUC-ROC) of the machine-learning model in predicting unexpected medical needs.

    From date of enrollment until the date of death, or assessed up to 26 weeks. Wearable device parameters are collected continuously. Other clinical assessments are performed every week. Events are recorded upon happening or afterwards.

Secondary Outcomes (3)

  • Correlation between symptoms and wearable device parameters

    From date of enrollment until the date of death, or assessed up to 26 weeks. Wearable device parameters are collected continuously. Symptoms assessed every week.

  • Correlation between Australia-modified Karnofsky Performance Status (AKPS) and wearable device parameters

    From date of enrollment until the date of death, or assessed up to 26 weeks. Wearable device parameters are collected continuously. Functional status assessed every week.

  • Correlation between palliative care phase and wearable device parameters

    From date of enrollment until the date of death, or assessed up to 26 weeks. Wearable device parameters are collected continuously. Palliative care phase assessed every week.

Other Outcomes (10)

  • Comparison of AUC-ROC in survival prediction between machine learning model and Palliative Performance Scale (PPS)

    From date of enrollment until the date of death, or assessed up to 26 weeks. PPS are assessed every week. Death or survival is recorded at the time the case closed.

  • Comparison of AUC-ROC in survival prediction between machine learning model and Glasgow Prognostic Score (GPS)

    GPS assessed retrospectively if data available. Death or survival is recorded at the time the case closed.

  • Comparison of AUC-ROC in survival prediction between machine learning model and Palliative Prognostic Index (PPI)

    From date of enrollment until the date of death, or assessed up to 26 weeks. PPI are assessed every week. Death or survival is recorded at the time the case closed.

  • +7 more other outcomes

Study Arms (1)

Wearable devices + Smartphone

The only arm in the study.

Eligibility Criteria

Age20 Years - 105 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Terminal cancer patients are receiving palliative care in outpatient clinic, home care or ward admission and will receive regular follow-up in the future.

You may qualify if:

  • Age: 20 years old or older
  • Clinical diagnosis: cancer in terminal stage.

You may not qualify if:

  • \- Cannot cooperate with use of wearable devices or smartphones.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

National Taiwan University Hospital

Taipei, 100, Taiwan

COMPLETED

National Taiwan University, Cancer Center

Taipei, 106, Taiwan

RECRUITING

Related Publications (2)

  • Pavic M, Klaas V, Theile G, Kraft J, Troster G, Blum D, Guckenberger M. Mobile Health Technologies for Continuous Monitoring of Cancer Patients in Palliative Care Aiming to Predict Health Status Deterioration: A Feasibility Study. J Palliat Med. 2020 May;23(5):678-685. doi: 10.1089/jpm.2019.0342. Epub 2019 Dec 23.

    PMID: 31873052BACKGROUND
  • Liu JH, Shih CY, Huang HL, Peng JK, Cheng SY, Tsai JS, Lai F. Evaluating the Potential of Machine Learning and Wearable Devices in End-of-Life Care in Predicting 7-Day Death Events Among Patients With Terminal Cancer: Cohort Study. J Med Internet Res. 2023 Aug 18;25:e47366. doi: 10.2196/47366.

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Jaw-Shiun Tsai, MDPHD

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jen-Hsuan Liu, MD

CONTACT

Jaw-Shiun Tsai, MDPHD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 30, 2021

First Posted

September 23, 2021

Study Start

September 23, 2021

Primary Completion

December 31, 2022

Study Completion

April 30, 2023

Last Updated

November 9, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations